ad image

IssueQ42015

1 / 1
Outsourcing Provides Advantages to Sponsor Companies

Outsourcing Provides Advantages to Sponsor Companies

Arto Toivonen

Fermion

PAP-Q4-15-CL-001Oct 01, 2015
Bolstering Capabilities for Parenteral Drug Development and Manufacturing

Bolstering Capabilities for Parenteral Drug Development and Manufacturing

Syed T. Husain

Alcami

PAP-Q4-15-CL-005Oct 01, 2015
Digital Automation in Clinical Trials: The Promise and Potential

Digital Automation in Clinical Trials: The Promise and Potential

Zaher El-Assi

Merge eClinical

PAP-Q4-15-CL-006Oct 01, 2015
Special Focus-Achieving Strong Customer Perception: The Customer Experience

Special Focus-Achieving Strong Customer Perception: The Customer Experience

Guy Tiene

Nice Insight

PAP-Q4-15-VP-001Oct 01, 2015
Be Innovative! Maneuvering the Global Pharmaceutical Market

Be Innovative! Maneuvering the Global Pharmaceutical Market

Nigel Walker

Nice Insight

PAP-Q4-15-NO-001Oct 01, 2015
Risk Minimization through Careful CDMO Selection

Risk Minimization through Careful CDMO Selection

Greg Flyte

GSK Contract Manufacturing

PAP-Q4-15-CL-003Oct 01, 2015
In-depth Process and Product Expertise – This is Key to CDMO Support of Orphan Drug and Breakthrough Therapy Development & Commercialization

In-depth Process and Product Expertise – This is Key to CDMO Support of Orphan Drug and Breakthrough Therapy Development & Commercialization

Kristine K. Senft

Nice Insight

PAP-Q4-15-CL-004Oct 01, 2015
What Does It Mean to be a Full-Service CDMO?

What Does It Mean to be a Full-Service CDMO?

Stephen A. Munk, Ph.D

Ash Stevens

PAP-Q4-15-CL-002Oct 01, 2015
Innovative Strategies to Meet Today’s Changing Equipment Needs

Innovative Strategies to Meet Today’s Changing Equipment Needs

Larry Kadis

Federal Equipment Company

PAP-Q4-15-CL-009Oct 01, 2015
Choosing the Optimal Drug Delivery System to Meet Patient Needs

Choosing the Optimal Drug Delivery System to Meet Patient Needs

Kevin Haehl

Unither Pharmaceuticals

PAP-Q4-15-CL-008Oct 01, 2015
Ensuring the Integrity of Temperature-Sensitive Drugs Along the Cold Chain: What You Can Do To Mitigate Risk

Ensuring the Integrity of Temperature-Sensitive Drugs Along the Cold Chain: What You Can Do To Mitigate Risk

Jay McHarg

AeroSafe Global

PAP-Q4-15-CL-007Oct 01, 2015
Cultural Competence In Pharma: Multicultural Marketing Is No Longer Innovation, It’s Competitive Advantage

Cultural Competence In Pharma: Multicultural Marketing Is No Longer Innovation, It’s Competitive Advantage

Rhea Kim, Ph.D.

Nice Consulting

PAP-Q4-15-NC-001Oct 01, 2015
1 / 1